Trials / Completed
CompletedNCT05214157
Optimizing Pain Management Following Laparoscopic Cholecystectomy RCT
A Prospective Randomized Controlled Study on the Role of Restoring Liver-Diaphragm Surface Tension and Pain Control at Port Sites in Optimizing Pain Management Following Laparoscopic Cholecystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 804 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
evaluating the two final steps we added to optimize post laparoscopic cholecystectomy pain management.
Detailed description
Introduction: After a laparoscopic cholecystectomy (LC), pain is still a significant concern, leading to extended hospital stays or readmissions. In majority of patients, postoperative pain medications are required. A standardized strategy is needed to offer effective pain relief postoperatively. The majority of pain in the early postoperative period is due to elimination of intraperitoneal surface tension or of parietal type. Aim of the work: to evaluate the two final steps we added to optimize postoperative pain management. Patients and methods: Over the period from March 2020 to December 2021, 816 patients with gallbladder stone undergoing LC were randomized into 2 groups after exclusion of 12 patients: Group A; interventional contained 402 patients. Group B; control contained 402 patients. Post-operative data to be compared were made in terms of operative time, shoulder pain, upper abdominal pain, (at 6,12,18 and 24 hours) and number of analgesic doses and hospital stay. Pain intensity was assessed by using the visual analogue scale (VAS) for each patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | active gas aspiration | sucking remaining Co2 from the peritoneal cavity and local anaesthetic application at port sites |
Timeline
- Start date
- 2020-03-20
- Primary completion
- 2021-12-31
- Completion
- 2022-01-08
- First posted
- 2022-01-28
- Last updated
- 2022-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05214157. Inclusion in this directory is not an endorsement.